Ethiopia
Tuberculosis profile
| High TB burden | High HIV burden | High MDR-TB burden |
Population  2012 92 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 16 (12–21) 18 (13–23)
Mortality (HIV+TB only) 5.6 (4.6–7.3) 6.1 (5–8)
Prevalence  (includes HIV+TB) 210 (170–250) 224 (180–272)
Incidence  (includes HIV+TB) 230 (170–290) 247 (183–321)
Incidence (HIV+TB only) 23 (17–30) 25 (19–33)
Case detection, all forms (%) 64 (49–87)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 47 236 (33) Relapse 1 820 (45)
Smear-negative 47 340 (33) Treatment after failure 281 (7)
Smear-unknown / not done 2 073 (1) Treatment after default 482 (12)
Extrapulmonary 46 854 (33) Other 1 506 (37)
Other 0 (0)      
Total new 143 503   Total retreatment 4 089  
           
Other (history unknown) 0        
Total new and relapse 145 323   Total cases notified 147 592  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio   1.2 1.1
Age < 15   7 682 7 852
Laboratories 2012
Smear (per 100 000 population) 2.8
Culture (per 5 million population) 0.3
Drug susceptibility testing (per 5 million population) <0.1
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 90   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 87  
Retreatment 78  
TB/HIV 2012 Number (%)
TB patients with known HIV status 96 245 (65)
HIV-positive TB patients 9 819 (10)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 3 619 (37)
HIV-positive TB patients on antiretroviral therapy (ART) 8 022 (82)
HIV-positive people screened for TB 272 178  
HIV-positive people provided with IPT 30 395  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.6 (0.86–2.8) 12 (5.6–21)
MDR-TB cases among notified pulmonary
TB cases
1 600 (830–2 700) 480 (230–870)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 469 (<1%) 180 (4%) 856
Laboratory-confirmed MDR-TB cases 30 102 284
Patients started on MDR-TB treatment     289
Financing TB control 2013
National TB programme budget (US$ millions) 145
% Funded domestically 17%
% Funded internationally 32%
% Unfunded 51%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-21 Data: www.who.int/tb/data